Dr Michael Morrison
|Tel||+44 (0)1865 287847|
STEMBANCC Researcher, HeLEX
Michael has an MA (by Research and Thesis) and PhD from the interdisciplinary Institute for Science and Society (ISS) at the University of Nottingham. He also holds a BSc in Biology from the University of St. Andrews (2000). He has previously been a researcher on the Framework Programme 7 Regenerative Medicine in Europe (REMEDiE) project at the University of York and with the Health Technology and Society group at the University of Exeter.
Michael’s primary research interest and expertise lies in the application of insights and perspectives from Science and Technology Studies (STS) and medical sociology to the study of novel and emerging biotechnologies. More specifically, he is concerned with understanding the ways in which these technologies are shaped by a variety of social factors – including institutional and regulatory cultures as well as the perspectives of developers and prospective users – throughout the course of their development and deployment into practice; and how, in turn, new biomedical technologies shape and reconfigure our understandings of disease, health, and the ‘sorts’ of people we are or can be.
Michael is currently working on the IMI STEMBANCC project, providing governance and ethical support to the project . He is also working with Jane Kaye and other HeLEX members to develop novel consent procedures for large-scale biobanking projects.
Infrastructural expectations: exploring the promise of international large-scale induced pluripotent stem cell banks
Morrison M., (2017), New Genetics and Society, 36, 66 - 83
Introduction to the article collection 'Translation in healthcare: ethical, legal, and social implications'.
Morrison M. et al, (2016), BMC Med Ethics, 17
Overdiagnosis, medicalisation and social justice: commentary on Carter et al (2016) ‘A definition and ethical evaluation of overdiagnosis’
Morrison M., (2016), Journal of Medical Ethics, medethics-2016-103717 - medethics-2016-103717
Between Scylla and Charybdis: Reconciling competing data management demands in the life sciences.
Bezuidenhout LM. and Morrison M., (2016), BMC Medical Ethics, 17
Traceability in stem cell research: from participant sample to induced pluripotent stem cell and back
Morrison M. et al, (2016), Regenerative Medicine, 11, 73 - 79